Corey Goodman

Président chez Mindrythm

Health Technology

Relations actives

Nom	Sexe	Age	Sociétés liées	Collaboration
William Hodder	M	-	NFlection Therapeutics, Inc. NFlection Therapeutics, Inc. BiotechnologyHealth Technology NFlection Therapeutics, Inc. operates as a biotechnology company. It focuses on the development of therapies for Neurofibromatosis. The company was founded by Mark de Souza and Michael Wootton in 2014 and is headquartered in Wayne, PA.	3 ans
Christopher Powala	M	64	NFlection Therapeutics, Inc. NFlection Therapeutics, Inc. BiotechnologyHealth Technology NFlection Therapeutics, Inc. operates as a biotechnology company. It focuses on the development of therapies for Neurofibromatosis. The company was founded by Mark de Souza and Michael Wootton in 2014 and is headquartered in Wayne, PA.	-
John Keane	M	-	Mindrythm Mindrythm Medical SpecialtiesHealth Technology Mindrythm is a brain wellness company based in San Francisco, CA. Mindrythm develops medical technology to prevent neurological injury, with a focus on stroke prevention. The company's proprietary monitoring devices and communication platform aim to solve the triage problem in stroke, potentially saving more than 200,000 lives in 2022. The company was founded by John Keane and Paul Lovoi, with John Keane serving as the CEO since incorporation.	-
Paul Lovoi	M	-	Mindrythm Mindrythm Medical SpecialtiesHealth Technology Mindrythm is a brain wellness company based in San Francisco, CA. Mindrythm develops medical technology to prevent neurological injury, with a focus on stroke prevention. The company's proprietary monitoring devices and communication platform aim to solve the triage problem in stroke, potentially saving more than 200,000 lives in 2022. The company was founded by John Keane and Paul Lovoi, with John Keane serving as the CEO since incorporation.	-
Joshua Grass	M	-	NFlection Therapeutics, Inc. NFlection Therapeutics, Inc. BiotechnologyHealth Technology NFlection Therapeutics, Inc. operates as a biotechnology company. It focuses on the development of therapies for Neurofibromatosis. The company was founded by Mark de Souza and Michael Wootton in 2014 and is headquartered in Wayne, PA.	-
Gerd Kochendoerfer	M	56	NFlection Therapeutics, Inc. NFlection Therapeutics, Inc. BiotechnologyHealth Technology NFlection Therapeutics, Inc. operates as a biotechnology company. It focuses on the development of therapies for Neurofibromatosis. The company was founded by Mark de Souza and Michael Wootton in 2014 and is headquartered in Wayne, PA.	3 ans
Jaume Pons	M	58	Alexo Therapeutics International Alexo Therapeutics International Pharmaceuticals: MajorHealth Technology Alexo Therapeutics International develops immune-oncology therapies for cancer. The company is headquartered in South San Francisco, CA.	-
Katen Patel	M	-	NFlection Therapeutics, Inc. NFlection Therapeutics, Inc. BiotechnologyHealth Technology NFlection Therapeutics, Inc. operates as a biotechnology company. It focuses on the development of therapies for Neurofibromatosis. The company was founded by Mark de Souza and Michael Wootton in 2014 and is headquartered in Wayne, PA.	-
Kenneth Tsai	M	-	NFlection Therapeutics, Inc. NFlection Therapeutics, Inc. BiotechnologyHealth Technology NFlection Therapeutics, Inc. operates as a biotechnology company. It focuses on the development of therapies for Neurofibromatosis. The company was founded by Mark de Souza and Michael Wootton in 2014 and is headquartered in Wayne, PA.	6 ans